Abstract
Glioma refers to the most atypical variant of the malignant central nervous system tumors posturing massive challenge to the research fraternity owing to the flimsy improvement in the patient survival rate over the past years. The aim of the proposed work was developing a diagnostic aid for brain tumors, which could be administered via the non-invasive intranasal route. Since overexpression of folate receptors in the central nervous system tumors is 500 times more than the normal healthy cells, we aimed at fabricating a radiolabeled folate encapsulated micellar delivery system to be given via the nasal route. Folate conjugated bifunctional chelating agent was synthesized, radiolabeled with 99mTc, and encapsulated in a micellar carrier. The fabricated micelles were further evaluated for in vivo nasal toxicity in rats and the same were found safe for intranasal administration. The fabricated micelles owing to their nano size, mucoadhesive nature, and enhanced permeation were observed to have a higher uptake into the brain (around 16% in 4 h) than as compared to the radiolabeled conjugated folate solution when studied for in vivo biodistribution in mice. Single-photon emission computerized tomography imaging performed in higher animals upon intranasal administration of the micellar formulation revealed enhanced uptake of the micelles into the animal brain. It is believed that the aforementioned formulation can be of a great diagnostic value in the detection of not only brain tumors but also other folate expressing cancers such as cervical, breast, and lungs as the system is fast, non-toxic, accurate, non-invasive, and simple.
Graphical Abstract
Similar content being viewed by others
Availability of data and materials
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Upadhaya PG, Pulakkat S, Patravale VB. Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management. Drug Deliv Transl Res. 2020;10:1044–56 Springer.
He Y, Wu C, Duan J, Miao J, Ren H, Liu J. Anti-glioma effect with targeting therapy using folate modified nano-micelles delivery curcumin. J Biomed Nanotechnol. 2020;16:1–13 American Scientific Publishers.
Basu B, Ghosh MK. Extracellular vesicles in glioma: from diagnosis to therapy. Bioessays. 2019;41:1800245 Wiley Online Library.
Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan C-N, Wolf AP. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med. 1978;19:1154–61 Soc Nuclear Med.
Hustinx R, Fosse P. PET in brain tumors. PET Clin. 2010;5:185–97 Elsevier.
Jung J, Ahn B-C. Current radiopharmaceuticals for positron emission tomography of brain tumors. Brain Tumor Res Treat. 2018;6:47 Korean Brain Tumor Society.
Anderson KE, Eliot LA, Stevenson BR, Rogers JA. Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form. Pharm Res. 2001;18:316–22 Springer.
Lee RJ, Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem. 1996;271:8481–7 Elsevier.
Mathias CJ, Wang S, Lee RJ, Waters DJ, Low PS, Green MA. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Med. 1996;37:1003–8 Citeseer.
McCord E, Pawar S, Koneru T, Tatiparti K, Sau S, Iyer AK. Folate receptors’ expression in gliomas may possess potential nanoparticle-based drug delivery opportunities. ACS Omega. 2021;6:4111–8 ACS Publications.
Vivek R, Rejeeth C, Thangam R. Targeted nanotherapeutics based on cancer biomarkers. In: Multifunctional systems for combined delivery, biosensing and diagnostics. Elsevier; 2007. p. 229–44.
Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem. 2005;338:284–93 Elsevier.
Wang S, Meng Y, Li C, Qian M, Huang R. Receptor-mediated drug delivery systems targeting to glioma. Nanomaterials. 2015;6:3 MDPI.
Panwar P, Shrivastava V, Tandon V, Mishra P, Chuttani K, Sharma RK, et al. 99mTc-Tetraethylenepentamine-folate a new 99mTc based folate derivative for the detection of folate receptor positive tumors: synthesis and biological evaluation. Cancer Biol Ther. 2004;3:995–1001 Taylor & Francis.
Mirani AG, Patravale VB. Design of experiments: basic concepts and its application in pharmaceutical product development. New York: Prof Patravale V, Dr Disouza J and Rustomjee M, CRC Press, Taylor and Francis Group; 2016.
Jain R, Patravale VB. Development and evaluation of nitrendipine nanoemulsion for intranasal delivery. J Biomed Nanotechnol. 2009;5:62–8 American Scientific Publishers.
Javadzadeh Y, Adibkia K, Hamishekar H. Transcutol®(diethylene glycol monoethyl ether): a potential penetration enhancer. In: Percutaneous penetration enhancers chemical methods in penetration enhancement. Springer; 2015. p. 195–205.
Mathias CJ, Hubers D, Low PS, Green MA. Synthesis of [99mTc] DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical. Bioconjug Chem. 2000;11:253–7 ACS Publications.
Brunello S, Salvarese N, Carpanese D, Gobbi C, Melendez-Alafort L, Bolzati C. A review on the current state and future perspectives of [99mTc] Tc-housed PSMA-i in prostate cancer. Molecules. 2022;27:2617 Multidisciplinary Digital Publishing Institute.
Narang AS, Delmarre D, Gao D. Stable drug encapsulation in micelles and microemulsions. Int J Pharm. 2007;345:9–25 Elsevier.
Shubber S, Vllasaliu D, Rauch C, Jordan F, Illum L, Stolnik S. Mechanism of mucosal permeability enhancement of CriticalSorb®(Solutol® HS15) investigated in vitro in cell cultures. Pharm Res. 2015;32:516–27 Springer.
Shah BM, Misra M, Shishoo CJ, Padh H. Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization. Drug Deliv. 2015;22:918–30 Taylor & Francis.
Nicolau Costa KM, Sato MR, Barbosa TLA, Rodrigues MGF, Medeiros ACD, Damasceno BPGDL, et al. Curcumin-loaded micelles dispersed in ureasil-polyether materials for a novel sustained-release formulation. Pharmaceutics. 2021;13:675 MDPI.
Manet S, Lecchi A, Impéror-Clerc M, Zholobenko V, Durand D, Oliveira CL, et al. Structure of micelles of a nonionic block copolymer determined by SANS and SAXS. J Phys Chem B. 2011;115:11318–29 ACS Publications.
Carlson TL, Lock JY, Carrier RL. Engineering the mucus barrier. Ann Rev Biomed Eng. 2018;20:197–220 Annual Reviews.
Mistry A, Stolnik S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm. 2009;379:146–57 Elsevier.
Fechter LD, Johnson DL, Lynch RA. The relationship of particle size to olfactory nerve uptake of a non-soluble form of manganese into brain. Neurotoxicology. 2002;23:177–83 Elsevier.
Vila A, Gill H, McCallion O, Alonso MJ. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Control Release. 2004;98:231–44 Elsevier.
Bejgum BC, Donovan MD. Uptake and transport of ultrafine nanoparticles (quantum dots) in the nasal mucosa. Mol Pharm. 2020;18:429–40 ACS Publications.
Vyas TK, Babbar AK, Sharma RK, Singh S, Misra A. Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting. J Pharm Sci. 2006;95:570–80 Elsevier.
Upadhaya P, Pulakkat S, Patravale V. Diagnostic and theranostic intranasal nanointerventions for brain diseases. In: Direct nose-to-brain drug delivery. Elsevier; 2021. p. 287–303.
Funding
Board of Research in Nuclear Sciences, Department of Atomic Energy, Government of India (35/14/15/2015-BRNS).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
The animal studies were performed as per the guidelines of the Institutional Animal Ethics Committee complying the current laws of the country.
Consent to participate
NA.
Consent for publication
NA.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Upadhaya, P., Hazari, P.P., Mishra, A.K. et al. Radiolabelled folate micellar carriers as proposed diagnostic aid for CNS tumors by nasal route. Drug Deliv. and Transl. Res. 13, 2604–2613 (2023). https://doi.org/10.1007/s13346-023-01341-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13346-023-01341-8